ITP ICD-10-CM Codes | 2023
Explore ICD-10-CM codes for Immune Thrombocytopenic Purpura (ITP) in 2023. Learn about common codes, billable statuses, and gain clinical insights in this comprehensive guide.
What ICD-10 Codes are Used for ITP
Immune Thrombocytopenic Purpura (ITP) is an autoimmune disorder characterized by a low platelet count. Here are commonly used ICD-10-CM codes for ITP, along with brief clinical descriptions:
- D69.3 - Immune thrombocytopenic purpura, unspecified: Used when ITP is diagnosed, but the specific type or cause is not further specified.
- D69.4 - Other primary thrombocytopenia: Applied for primary thrombocytopenias that are not classified as ITP or other specific types.
- D69.5 - Secondary thrombocytopenia: Utilized for thrombocytopenia secondary to an underlying condition or medication, which may include ITP secondary to other illnesses or drugs.
- D69.6 - Thrombocytopenia, unspecified: Used for cases of thrombocytopenia when the specific type is not diagnosed or documented.
Which ITP ICD Codes are Billable
The billable status of the mentioned ICD-10 codes for ITP varies:
- D69.3 - Immune thrombocytopenic purpura, unspecified: Yes, billable. Medical expenses for ITP can be claimed.
- D69.4 - Other primary thrombocytopenia: Yes, billable. Costs associated with other primary thrombocytopenias can be reimbursed.
- D69.5 - Secondary thrombocytopenia: Yes, billable. Medical expenses for secondary thrombocytopenia can be claimed.
- D69.6 - Thrombocytopenia, unspecified: Yes, billable. Expenses related to unspecified thrombocytopenia can be reimbursed.
Clinical Information
- Idiopathic Thrombocytopenic Purpura (ITP) is a blood disorder characterized by a low platelet count, which can lead to easy bruising, bleeding, and a skin rash called purpura.
- Diagnosis involves a complete blood count (CBC) to assess platelet levels and a peripheral blood smear to examine the platelets' appearance.
- ITP is often called "idiopathic" because the exact cause is unknown. It's believed to involve the immune system mistakenly attacking and destroying platelets.
- Treatment options vary based on the severity of symptoms. In mild cases, observation and monitoring may be sufficient.
- In more severe cases, treatment may include corticosteroids, intravenous immunoglobulin (IVIG), or medications that suppress the immune system.
- Some patients may require splenectomy (removal of the spleen) if other treatments are ineffective.
- Patient education should include information on recognizing bleeding symptoms, avoiding medications that can worsen platelet counts (like certain pain relievers), and adherence to treatment plans.
- Regular follow-up is essential to monitor platelet counts and adjust treatment as needed.
- Healthcare practitioners are critical in managing ITP, providing support and education to patients to improve their quality of life and reduce the risk of bleeding complications.
Synonyms Include
- ITP (Immune Thrombocytopenic Purpura)
- Thrombocytopenia
- Low Platelet Count
- Platelet Disorder
- ICD-10 ITP
- Autoimmune Platelet Disorder
Commonly asked questions
ITP is an autoimmune disorder, which means it occurs when the immune system mistakenly targets and destroys platelets. The exact cause is often unknown.
Treatment for ITP depends on the severity of symptoms. It may include medications to suppress the immune system, steroids, IVIG, or, in severe cases, spleen removal (splenectomy) to reduce platelet destruction.
Yes, ITP can be chronic, lasting for an extended period. However, the course of the disease varies from person to person. Some individuals may have short-term or acute ITP, while others may experience a chronic form. Regular medical monitoring and treatment can help manage the condition.